Skip to main content

Table 1 Baseline characteristics of patients with acute leukemia

From: Simplified predictive scores for thrombosis and bleeding complications in newly diagnosed acute leukemia patients

Factor

Total

(N = 261)

(100%)

ALL (A)

(N = 70)

(26.8%)

APL (B)

(N = 24)

(9.2%)

AML (C)

(N = 167)

(64.0%)

P

P for multiple comparisons

A vs. B

A vs. C

B vs. C

Sex

    

0.314

0.151

0.280

0.398

 -Female

125 (47.9%)

29 (41.4%)

14 (58.3%)

82 (49.1%)

    

 -Male

136 (52.1%)

41 (58.6%)

10 (41.7%)

85 (50.9%)

    

Median age (IQR) (years)

49 (35–61)

35 (22–58)

43 (34–48)

55 (40–63)

 < 0.001

0.336

 < 0.001

0.001

Clinical features of major bleeding (WHO grade 4)

 -Oropharyngeal

4 (1.5%)

4 (5.7%)

0 (0%)

0 (0%)

    

 -Epistaxis

3 (1.1%)

2 (2.9%)

0 (0%)

1 (0.6%)

    

 -Hemoptysis

5 (1.9%)

1 (1.4%)

1 (4.2%)

3 (1.8%)

    

 -UGIB

7 (2.7%)

2 (2.9%)

0 (0%)

5 (3.0%)

    

 -LGIB

6 (2.3%)

3 (4.3%)

0 (0%)

3 (1.8%)

    

 -Hematuria

4 (1.5%)

3 (4.3%)

1 (4.2%)

0 (0%)

    

 -Vaginal bleeding

4 (1.5%)

1 (1.4%)

2 (8.2%)

1 (0.6%)

    

 -Muscle hematoma

1 (0.4%)

0 (0%)

1 (4.2%)

0 (0%)

    

 -Retinal hemorrhage

8 (3.1%)

5 (7.1%)

0 (0%)

3 (1.8%)

    

 -Intracerebral hemorrhage

8 (3.1%)

1 (1.4%)

2 (8.3%)

5 (3.0%)

    

 -Overall bleeding events (numbers of patients)

50 (44 patients)

22 (18 patients)

7 (6 patients)

21 (20 patients)

0.019

0.945

0.009

0.107

Clinical features of thrombosis

 -Deep vein thrombosis

2 (0.8%)

0 (0%)

0 (0%)

2 (1.2%)

    

 -Pulmonary embolism

5 (1.9%)

1 (1.4%)

2 (8.3%)

2 (1.2%)

    

 -Acute arterial occlusion

1 (0.4%)

0 (0%)

1(4.2%)

0 (0%)

    

 -Splenic infarction

2 (0.8%)

0 (0%)

0 (0%)

2 (1.2%)

    

 -Acute cerebral infarction

7 (2.7%)

2 (2.9%)

0 (0%)

5 (3.0%)

    

 -Overall thrombotic events (numbers of patients)

17 (16 patients)

3 (3 patients)

3 (2 patients)

11 (11 patients)

0.719

0.599

0.763

0.670

Laboratory at diagnosis

 Mean ± SD

  -Hemoglobin (g/L)

78 ± 23

87 ± 24

84 ± 23

74 ± 21

 < 0.001

0.582

 < 0.001

0.035

 Median (IQR)

  -WBC (× 109/L)

18.50 (3.96–95.50)

26.72 (4.30–116.63)

4.66 (1.20–26.09)

18.27 (4.52–86.31)

0.012

0.008

0.476

0.005

  -Platelet (× 109/L)

40.00 (18.00–81.00)

50.50 (21.00–94.00)

33.00 (20.00–49.00)

37.00 (16.00–73.00)

0.297

0.151

0.210

0.554

  -PT (seconds)

14.0 (13.0–15.6)

13.6 (12.5–15.3)

14.1 (13.4–16.8)

14.0 (13.1–15.6)

0.189

0.130

0.127

0.467

  -APTT (seconds)

26.1 (23.8–29.4)

26.9 (23.9–28.9)

25.5 (23.8–30.2)

25.8 (23.5–29.5)

0.928

0.745

0.725

0.976

  -Fibrinogen (mg/dL)

349 (247–453)

338 (219–436)

153 (123–287)

372 (272–484)

 < 0.001

 < 0.001

0.044

 < 0.001

  -D-dimer (µg FEU/L)

3,259.1 (1,120.0–8,492.5)

4,034.7 (1,338.6–9,145.9)

9,308.5 (5,490.2–10,000.0)

2,394.4 (967.5–6,502.0)

 < 0.001

0.001

0.057

 < 0.001

Median ISTH-DIC scores

3 (2–5)

3 (1–5)

5 (4–6)

3 (2–4)

 < 0.001

0.001

0.479

 < 0.001

Numbers of overt DIC

75 (28.7%)

20 (28.6%)

15 (62.5%)

40 (24.0%)

 < 0.001

0.003

0.456

 < 0.001

  1. Abbreviations: ALL Acute lymphoblastic leukemia, AML Acute myeloid leukemia, APL Acute promyelocytic leukemia, APTT Activated partial thromboplastin time, DIC Disseminated intravascular coagulation, FEU Fibrinogen equivalent units, IQR Interquartile range, ISTH The International Society on Thrombosis and Haemostasis, LGIB lower gastrointestinal bleeding, PT Prothrombin time, SD Standard deviation, UGIB Upper gastrointestinal bleeding, WBC White blood cell